Neurology Dissertation Topics for 2026

Questions Students Are Asking About Neurology Dissertations

The following questions have been gathered from student forums, academic discussion boards, and higher education Q&A platforms. They reflect the real concerns and search habits of students preparing for their neurology dissertations.

• What are the best neurology dissertation topics for 2026?
• How do I choose a dissertation topic in neurology that is original and researchable?
• Which neurological research topics are suitable for a master’s or PhD-level study?
• What are the latest neurology research topics I should be aware of?
• Can I get neurology dissertation topics with examples to help me understand the structure?
• Are there topics in neurology that connect clinical practice with current research gaps?
• What neuroscience dissertation topics are relevant to both medicine and psychology students?

Introduction: Why Choosing the Right Neurology Dissertation Topic Matters

Choosing the right dissertation topic in neurology is one of the most critical decisions a student will make during their academic journey. Neurology sits at the intersection of medicine, biology, psychology, and technology, which makes the field rich with research possibilities but also complex to navigate. A poorly defined topic can lead to vague research questions, weak arguments, and a dissertation that fails to contribute meaningfully to the field.

On the other hand, a well-chosen topic gives your study a clear purpose. It helps you align your research with current clinical needs, policy developments, and scientific advances. Whether you are an undergraduate exploring brain disorders research topics for the first time or a doctoral candidate working on something highly specialised, the right topic shapes every part of your dissertation: the methodology, the literature review, and the conclusions you draw.

This post is designed to help you move from confusion to clarity. It explains what to look for in a strong neurology dissertation topic, walks you through how topics are structured, and provides more than 100 ready-to-explore ideas across all major subfields.

Download Neurology Dissertation Topics PDF

If you would like a personalised list of dissertation topics prepared by academic experts, you can request a downloadable PDF version of this topic list. The PDF is curated based on your academic level, specialisation, and research interests. Students working on neurology dissertation help often find a tailored topic list saves considerable time during the proposal stage. Reach out through the contact form on this page to receive your copy.

Why the Right Neurology Dissertation Topic Makes a Difference

The field of neurology covers an enormous range of conditions, mechanisms, and treatments. From Alzheimer’s disease to epilepsy, from spinal cord injuries to rare genetic disorders, the research landscape is vast. This breadth is exciting, but it can also make topic selection feel overwhelming.

When students select a topic that is too broad, they end up producing a review rather than a research study. When a topic is too narrow without adequate literature, they struggle to find sufficient evidence to build an argument. The ideal dissertation topic in neurology is one that is specific enough to be researchable within your time frame, yet broad enough to have a body of existing academic literature to engage with.

Supervisors and examination boards also assess whether your topic reflects awareness of current academic conversations. Choosing a topic that was heavily researched a decade ago without a fresh angle can limit the originality of your work. Choosing a topic aligned with 2026-level concerns, such as the use of data analytics in neuroimaging or the ethics of AI-assisted diagnosis, signals academic awareness and intellectual relevance.

Key Research Areas in Neurology for 2026

Before diving into individual topics, it is useful to understand the major research areas that are shaping the field. These areas provide a framework for narrowing your focus.

Neurodegenerative Disorders

This area covers conditions such as Alzheimer’s disease, Parkinson’s disease, and motor neurone disease. Research in this space focuses on early detection, disease progression, genetic factors, and emerging therapeutic approaches. It remains one of the most active areas in neurological research globally.

Cerebrovascular Disease and Stroke

Stroke research explores prevention, acute management, rehabilitation, and long-term outcomes. It increasingly intersects with public health, as stroke prevention requires systemic changes in diet, lifestyle, and healthcare access. This area offers strong opportunities for clinical and community-based research.

Epilepsy and Seizure Disorders

Epilepsy remains one of the most common serious neurological conditions worldwide. Research topics in this area include drug-resistant epilepsy, surgical interventions, the neuropsychological impact of seizures, and patient quality of life. There is also growing interest in how data analytics can improve seizure prediction.

Multiple Sclerosis and Autoimmune Neurology

Multiple sclerosis research has expanded significantly in recent years, particularly in relation to disease-modifying therapies and the role of the immune system. Autoimmune encephalitis and related conditions are also emerging as important areas for dissertation-level study.

Neuro-oncology

Brain and spinal cord tumours present some of the most challenging research questions in medicine. Topics here can explore treatment options, quality of life for patients, biomarker discovery, and the psychological impact of diagnosis.

Neuropsychiatry and Cognitive Neuroscience

The boundary between neurology and psychiatry is increasingly blurred. Cognitive decline, traumatic brain injury, depression linked to neurological conditions, and dementia-related behavioural changes are all areas ripe for original research.

Paediatric Neurology

Children with neurological conditions present distinct clinical and ethical challenges. Research areas include developmental delays, childhood epilepsy, cerebral palsy, and the long-term neurodevelopmental impact of early medical interventions.

Neurorehabilitation and Quality of Life

This area focuses on how patients recover from neurological events and how their quality of life is sustained. It draws on physiotherapy, occupational therapy, psychology, and health policy.

Five Neurology Dissertation Topics With Examples

Understanding how a dissertation topic is structured helps you build a stronger proposal. Below are five example topics with a research aim and supporting objectives. These are suitable for master’s and PhD candidates.

Example 1: Early Biomarkers in Alzheimer’s Disease

Research Aim: To evaluate the predictive accuracy of blood-based biomarkers in identifying early-stage Alzheimer’s disease in adults over 60.

Research Objectives:

• To review existing literature on blood-based biomarker panels currently used in Alzheimer’s detection.
• To compare the sensitivity and specificity of different biomarker combinations in clinical trial data.
• To assess the implications of early diagnosis on patient care planning and therapeutic outcomes.

Example 2: Digital Therapeutics in Parkinson’s Disease Management

Research Aim: To examine the effectiveness of smartphone-based digital therapeutics in managing motor symptoms of Parkinson’s disease.

Research Objectives:

• To identify and critically assess existing digital therapeutic tools designed for Parkinson’s patients.
• To evaluate patient adherence and engagement data reported in clinical studies.
• To explore the barriers to adoption of digital tools among elderly neurological patients.

Example 3: Drug-Resistant Epilepsy and Surgical Outcomes

Research Aim: To assess the long-term seizure-freedom rates following surgical intervention in patients with drug-resistant epilepsy.

Research Objectives:

• To review surgical techniques and their reported outcomes in peer-reviewed clinical literature.
• To identify patient-specific factors that predict surgical success.
• To examine quality-of-life outcomes post-surgery compared to continued pharmacological management.

Example 4: Gender Differences in Multiple Sclerosis Progression

Research Aim: To investigate whether biological sex influences the rate of disability progression in patients with relapsing-remitting multiple sclerosis.

Research Objectives:

• To analyse longitudinal data comparing male and female patients with established MS diagnoses.
• To review hormonal factors proposed as contributors to sex-based differences in disease activity.
• To assess implications for sex-specific treatment protocols in clinical practice.

Example 5: Stroke Rehabilitation and Remote Physiotherapy

Research Aim: To evaluate the clinical effectiveness of remote physiotherapy delivery in post-stroke rehabilitation compared to in-person care.

Research Objectives:

• To compare functional recovery outcomes between patients receiving remote and in-person physiotherapy.
• To assess patient satisfaction and therapy adherence in telehealth-based rehabilitation programmes.
• To identify technical and logistical barriers to implementing remote stroke rehabilitation at scale.

100+ Neurology Dissertation Topics for 2026

The following topics are organised by subfield. They are intended to inspire and guide. Each one is specific, academically grounded, and suitable for undergraduate, master’s, or PhD-level research proposals. Use them as starting points and refine them with your supervisor’s input.

Alzheimer’s Disease and Dementia Research

1. The role of tau protein accumulation in predicting cognitive decline in early Alzheimer’s disease.
2. A critical analysis of cholinesterase inhibitors in slowing Alzheimer’s progression in community-dwelling adults.
3. The psychological burden of caregiving for individuals with advanced Alzheimer’s disease in the UK.
4. Exploring the link between midlife hypertension and late-onset Alzheimer’s disease risk.
5. Sleep disturbances as early indicators of Alzheimer’s pathology: a systematic review.
6. Racial and ethnic disparities in Alzheimer’s diagnosis rates across the NHS.
7. Evaluating the impact of lifestyle interventions on cognitive resilience in pre-dementia adults.
8. How does social isolation accelerate dementia progression in older adults living alone?
9. The accuracy of AI-assisted neuroimaging in detecting Alzheimer’s biomarkers at pre-symptomatic stages.
10. Ethical considerations surrounding predictive genetic testing for familial Alzheimer’s disease.

Parkinson’s Disease and Movement Disorders

11. Non-motor symptoms of Parkinson’s disease and their impact on patient-reported quality of life.
12. The therapeutic potential of deep brain stimulation in reducing tremor severity in Parkinson’s patients.
13. Gut microbiome alterations as a potential early biomarker for Parkinson’s disease.
14. Evaluating the effectiveness of physiotherapy protocols in maintaining mobility in advanced Parkinson’s.
15. Occupational therapy interventions for preserving independence in early-stage Parkinson’s disease.
16. Lewy body dementia versus Parkinson’s disease dementia: clinical overlap and diagnostic challenges.
17. How wearable technology can improve medication adherence monitoring in Parkinson’s patients.
18. Genetic risk factors in early-onset Parkinson’s disease: a literature-based analysis.
19. The role of dopamine dysregulation syndrome in impulsive behaviours among Parkinson’s patients on dopamine agonists.
20. Fatigue in Parkinson’s disease: prevalence, mechanisms, and management strategies.

Epilepsy and Seizure Disorders

21. Ketogenic diet as a non-pharmacological intervention in paediatric drug-resistant epilepsy.
22. A comparative analysis of anti-epileptic drug regimens in newly diagnosed adult epilepsy patients.
23. The impact of epilepsy on mental health and social functioning in university-aged students.
24. Neuromodulation devices for epilepsy management: a systematic review of clinical outcomes.
25. Investigating the underdiagnosis of epilepsy in adults with intellectual disabilities.
26. Predicting seizure onset using machine learning applied to EEG data: a clinical review.
27. The long-term cognitive effects of sodium valproate in women of childbearing age with epilepsy.
28. Sudden unexpected death in epilepsy (SUDEP): risk factors, prevention, and patient awareness.
29. Status epilepticus in the emergency setting: a review of current treatment protocols.
30. Stigma, identity, and self-management in adults living with epilepsy in the United Kingdom.

Stroke and Cerebrovascular Disease

31. Thrombolysis within the extended treatment window: outcomes and eligibility criteria for ischaemic stroke.
32. The effectiveness of transient ischaemic attack clinics in preventing subsequent stroke events.
33. Racial disparities in stroke incidence and post-stroke care within NHS-funded services.
34. Post-stroke depression: prevalence, screening tools, and treatment approaches.
35. The role of atrial fibrillation management in reducing cardioembolic stroke risk.
36. Cognitive impairment following minor stroke: a longitudinal analysis.
37. Rehabilitation robotics in post-stroke motor recovery: clinical effectiveness and patient perspectives.
38. Intracerebral haemorrhage management: comparing surgical and conservative treatment approaches.
39. Secondary stroke prevention adherence in minority ethnic populations in the United Kingdom.
40. The neuropsychological sequelae of subarachnoid haemorrhage and their impact on return to work.

Multiple Sclerosis and Autoimmune Neurology

41. Patient adherence to disease-modifying therapies in relapsing-remitting multiple sclerosis.
42. Fatigue in multiple sclerosis: measurement challenges and therapeutic approaches.
43. Exploring the relationship between vitamin D deficiency and multiple sclerosis relapse rates.
44. Cognitive reserve and its protective role in slowing cognitive decline in multiple sclerosis.
45. The quality of life impact of bladder dysfunction in women with multiple sclerosis.
46. Autoimmune encephalitis: diagnostic delays and their impact on patient outcomes.
47. Anti-NMDA receptor encephalitis: clinical presentation, treatment, and long-term prognosis.
48. Natalizumab versus ocrelizumab in highly active relapsing-remitting multiple sclerosis: a comparative review.
49. Paediatric multiple sclerosis: clinical characteristics and outcomes compared to adult-onset disease.
50. The psychological experience of disease uncertainty in patients newly diagnosed with multiple sclerosis.

Neurodegenerative Disorders (Broader Category)

51. Frontotemporal dementia: clinical heterogeneity and challenges in diagnostic classification.
52. The role of neuroinflammation in the progression of amyotrophic lateral sclerosis.
53. Huntington’s disease: the psychological impact on presymptomatic carriers aware of their genetic status.
54. Progressive supranuclear palsy: delayed diagnosis and its effect on patient management.
55. Mitochondrial dysfunction as a common pathway in neurodegenerative disorders: a thematic review.
56. The potential of stem cell therapy in treating motor neurone disease: current evidence and ethical limits.
57. Rare neurodegenerative conditions and the challenge of conducting meaningful clinical trials with small patient populations.
58. Corticobasal syndrome: clinical overlap with Parkinson’s disease and diagnostic accuracy.
59. Prion diseases: public health implications and surveillance approaches in the UK.
60. Biomarker development for neurodegenerative disorders: translating laboratory findings into clinical practice.

Brain Tumours and Neuro-Oncolog

61. Quality of life in glioblastoma multiforme patients receiving concurrent chemoradiotherapy.
62. Bevacizumab in recurrent high-grade glioma: a systematic review of clinical trial outcomes.
63. Psychological distress in brain tumour patients: the unmet need for specialist palliative support.
64. The diagnostic utility of liquid biopsies in detecting brain tumour recurrence.
65. Cognitive rehabilitation for patients with brain tumours undergoing radiotherapy.
66. Meningioma management: active surveillance versus surgical intervention in asymptomatic patients.
67. Paediatric brain tumours and the long-term neurodevelopmental consequences of radiotherapy.
68. Tumour treating fields therapy: patient experience and clinical outcomes in glioblastoma.
69. The role of the blood-brain barrier in limiting drug delivery to central nervous system tumours.
70. Health-related quality of life assessment tools in neuro-oncology: a critical comparison.

Neuropsychiatry and Cognitive Neuroscience

71. Functional neurological symptom disorder: stigma, misdiagnosis, and treatment pathways.
72. Traumatic brain injury and its association with long-term risk of psychiatric disorder.
73. Cognitive decline in HIV-positive adults on long-term antiretroviral therapy.
74. The neurological basis of obsessive-compulsive disorder: a review of neuroimaging evidence.
75. Neuropsychological outcomes following cardiac arrest and hypoxic brain injury.
76. The relationship between chronic pain and structural brain changes in fibromyalgia.
77. Post-COVID-19 neurological syndrome: characterising cognitive symptoms and recovery trajectories.
78. Sleep architecture and its role in memory consolidation and neurological health.
79. The neuropsychological profile of post-traumatic stress disorder: implications for clinical assessment.
80. Depression in neurological conditions: is it underdiagnosed, undertreated, or both?

Paediatric Neurolog

81. Cerebral palsy and the effectiveness of early intervention physiotherapy on motor outcomes.
82. Attention deficit hyperactivity disorder (ADHD) and its neurological underpinnings: a review of current evidence.
83. The impact of neonatal hypoxic-ischaemic encephalopathy on long-term neurodevelopmental outcomes.
84. Childhood absence epilepsy: natural history, educational impact, and treatment approaches.
85. Autism spectrum disorder and comorbid epilepsy: prevalence and clinical management.
86. Paediatric migraine: under-recognition in primary care and strategies for improving diagnosis.
87. The neurological complications of childhood meningitis and long-term surveillance requirements.
88. Tics and Tourette syndrome in school-aged children: impact on academic performance and social participation.
89. Spinal muscular atrophy and access to gene therapy in the NHS: equity, eligibility, and outcomes.
90. Transition from paediatric to adult neurology services: patient experience and clinical continuity.

Neurorehabilitation and Clinical Outcomes

91. Upper limb robotic rehabilitation following stroke: a systematic review of randomised controlled trials.
92. Fatigue management programmes for people with acquired brain injury: effectiveness and feasibility.
93. Community reintegration after traumatic brain injury: a qualitative exploration of patient experiences.
94. Virtual reality in neurological rehabilitation: clinical evidence and patient acceptability.
95. Constraint-induced movement therapy in chronic stroke: outcomes and patient motivation factors.
96. Falls prevention programmes for people with Parkinson’s disease in community settings.
97. The role of speech and language therapy in managing dysphagia following neurological events.
98. Neurological rehabilitation in low-resource settings: evidence gaps and ethical considerations.
99. Long-term outcomes following intensive inpatient rehabilitation for acquired brain injury.
100. Caregiver burden and psychological well-being in families supporting adults with severe neurological disability.

Emerging Areas in Clinical Neurology

101. The ethics of predictive neurogenetics: what patients and clinicians need to understand.
102. Artificial intelligence in neurological diagnosis: reliability, bias, and clinical governance concerns.
103. Teleneurology and its impact on rural access to specialist neurological care in the UK.
104. Psychedelic-assisted therapy for neurological and psychiatric comorbidities: current evidence and risks.
105. The neurological effects of long-term cannabis use: a systematic review of cohort studies.
106. Circadian rhythm disruption and its contribution to neurodegenerative disorder risk.
107. Precision medicine approaches in epilepsy treatment: aligning genetic profiling with drug selection.
108. The role of the lymphatic system in brain waste clearance and its relevance to neurodegeneration.
109. Neurological complications of systemic autoimmune diseases: diagnostic and treatment challenges.
110. Brain-computer interface technology in communication for patients with locked-in syndrome.

Conclusion: Moving Forward With Confidence in Your Neurology Dissertation

Selecting a dissertation topic is not just an academic formality. It is the foundation of everything that follows. A well-chosen topic allows you to ask meaningful questions, apply appropriate research methods, and contribute something of value to the field of neurology.

This post has covered the major research areas within neurology, provided structured examples of how topics are developed with clear aims and objectives, and presented over 100 original ideas across every major subfield. Whether you are working on clinical neurology topics at undergraduate level or exploring complex neuroscience dissertation topics at doctoral level, there is a research path here suited to your interests and capabilities.

The most important step you can take now is to choose a topic that genuinely interests you, discuss it with your supervisor, and begin reading the relevant literature. Passion for your subject makes the research process far more sustainable, especially during the longer stages of writing and analysis.

If you are still unsure or would like guidance tailored to your academic level and specialisation, professional academic support is available. A good starting point is reaching out for expert advice before committing to a topic, rather than after you have already begun. Students seeking targeted neurology dissertation help will benefit most when that support is sought early in the process.

Approach your dissertation with curiosity, academic rigour, and confidence. The field of neurology needs researchers who care about the work they are doing, and your dissertation is your first real opportunity to contribute to that legacy.